Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
JANX
Home
/
JANX

NASDAQ
$18.18
$18.18

Overview

Price performance
Low
$17.43
High
$18.33
After hours. Last updated: Nov 4, 2026, 9:00 PM UTC
$
18.18
0.36 (2.02%)
Average, 50 days
$17.58
$15.37
Open
$18.33
Previous close
$17.82
52-week high
$35.34
Nov 26, 2025 (1 year ago)
52-week low
$12.12
Feb 5, 2026 (10 months ago)
50.00%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
1.11B
Volume
976 175
Total Return (3M)
13.91%
Total Return (1Y)
-32.69%
—
Sector
Healthcare
Links
Tags
Healthcare
Biotechnology
NASDAQ
US
Website
januxrx.com
About
Janux Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. The firm leverages its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to create treatments designed to activate the body's T cells to fight tumors. Currently, Janux has several promising TRACTr product candidates in their early preclinical or discovery stages, which are engineered to target specific antigens such as prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. In addition to its TRACTr pipeline, the company is also developing a Tumor Activated Immunomodulator (TRACIr) — a costimulatory bispecific candidate designed to enhance T cell anti-tumor activity by engaging with programmed death-ligand 1 and CD28. Furthermore, a specific focus for their EGFR-TRACTr program is addressing epidermal growth factor receptor, a target prevalent in many cancer types and already a focus of numerous approved monoclonal antibody treatments. Janux Therapeutics, Inc. was founded in 2017 and is headquartered in La Jolla, California.

Frequently asked questions

JANX · Janux Therapeutics, Inc.

01What is Janux Therapeutics, Inc. stock price today?

The current price of JANX is $18.18 — it has increased by 2.02% since the previous close. Data as of Nov 4, 2026.

02Is Janux Therapeutics, Inc. stock price growing?

JANX is up 1.39% over the past week, up 7.38% over the past month and down 32.69% over the past year. The price is above its 200-day moving average of $15.37.

03What is Janux Therapeutics, Inc. market cap?

Janux Therapeutics, Inc. has a market capitalization of $1.11B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

04How volatile is JANX stock?

In the latest trading session JANX moved between $17.43 and $18.33, a range of 4.95% of its current price.

05What are JANX stock 52-week high and low?

Over the past 52 weeks JANX has traded between $12.12 and $35.34. The current price is 48.56% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.